QEFA - ETF AI Analysis

Top Page

SPDR MSCI EAFE StrategicFactors ETF (QEFA)

Rating:65Neutral

Price Target:―

QEFA, the SPDR MSCI EAFE StrategicFactors ETF, earns a solid overall rating thanks to high-quality core holdings like Novartis, AstraZeneca, and ASML, which combine strong financial performance, healthy balance sheets, and supportive earnings commentary to underpin the fund’s quality and growth potential. Additional positions such as Nestlé, TotalEnergies, and Zurich Insurance add stability through solid cash flows, reasonable valuations, and dividends, though some names like Shell, Unilever, BHP, and Zurich face short-term technical or growth challenges that slightly weigh on the fund. The main risk factor is its concentration in a relatively small group of large non-U.S. companies and sectors, where valuation concerns and periods of weak price momentum could create bouts of volatility.

Positive Factors

Broad International Diversification

The fund spreads its investments across many developed markets like Japan, the UK, Switzerland, and several others, which helps reduce reliance on any single country.

Balanced Sector Mix

Holdings are spread across financials, industrials, health care, consumer sectors, and technology, helping cushion the impact if one industry struggles.

Solid Size and Recent Performance

With over a billion in assets and steady gains over the past month, three months, and year-to-date, the ETF appears to have healthy investor interest and momentum.

Negative Factors

Mixed Performance Among Top Holdings

While some leading positions like ASML and major health care names have been strong, several other large holdings have shown weak or negative performance this year, which can drag on returns.

Concentration in a Few Countries

A large share of the portfolio is tied up in Japan and the UK, so setbacks in these markets could have an outsized impact on the fund.

Moderate Expense Ratio

The fund’s expense ratio is not especially low for an ETF, meaning fees may eat into returns more than with some cheaper index alternatives.

QEFA vs. SPDR S&P 500 ETF (SPY)

AUM1.04B

RegionDeveloped Markets

Expense Ratio0.30%

Beta0.57

IssuerState Street

Inception DateJun 04, 2014

Dividend Yield3%

Asset ClassEquity

Index TrackedMSCI EAFE Factor Mix A-Series (USD)

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume32,834

30 Day Avg. Volume35,537

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

104.76

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering650

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

QEFA Summary

QEFA is an ETF that follows the MSCI EAFE Factor Mix A-Series Index, investing in large and mid-sized companies in developed markets outside North America, such as Japan, the UK, and Europe. It spreads money across many sectors, including financials, healthcare, and technology. Well-known holdings include Nestlé, ASML, Novartis, and AstraZeneca. Someone might invest in QEFA to diversify beyond U.S. stocks and seek long-term growth from established international markets while staying broadly spread out. A key risk is that international stock prices can go up and down with global markets and currency swings.

How much will it cost me?The SPDR MSCI EAFE StrategicFactors ETF (Ticker: QEFA) has an expense ratio of 0.3%, meaning you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to incorporate multiple investment factors like value, low volatility, and quality into its strategy.

What would affect this ETF?The QEFA ETF, which focuses on developed markets outside North America, could benefit from stable economic growth in Europe and Asia, as well as increased demand for high-quality and low-volatility stocks in sectors like healthcare and consumer defensive. However, it may face challenges from rising interest rates, which could pressure financial and real estate sectors, and geopolitical tensions or regulatory changes in its key regions could negatively impact its top holdings and overall performance.

QEFA Top 10 Holdings

QEFA is leaning heavily on big European health-care names, with Novartis, Roche, AstraZeneca, and GSK all rising and effectively acting as the fund’s growth engine. ASML adds a powerful semiconductor twist, also climbing and giving the portfolio a tech edge despite its richer valuation. On the defensive side, consumer staples like Nestlé and Unilever are steady contributors, helping smooth out bumps. Energy players Shell and TotalEnergies are quietly supportive, while Zurich Insurance is one of the few laggards. Overall, it’s a developed-markets ex-North America story, anchored in Europe.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
NOVN	Novartis AG	2.37%	$24.35M	CHF238.47B	23.59%	80 Outperform
ASML	ASML Holding NV	2.22%	$22.78M	€438.37B	77.64%	76 Outperform
ROG	Roche Holding AG	1.96%	$20.13M	CHF265.95B	26.59%	73 Outperform
AZN	AstraZeneca	1.93%	$19.76M	$300.78B	21.96%	80 Outperform
NESN	Nestlé SA	1.77%	$18.19M	CHF202.47B	0.30%	71 Outperform
SHEL	Shell (UK)	1.36%	$13.93M	£180.69B	24.64%	73 Outperform
ULVR	Unilever	1.24%	$12.70M	£107.15B	―	72 Outperform
TTE	TotalEnergies SE	1.05%	$10.75M	€147.35B	21.74%	78 Outperform
BHP	BHP Group Ltd	1.00%	$10.23M	AU$254.42B	50.21%	68 Neutral
ZURN	Zurich Insurance Group	0.96%	$9.84M	CHF79.11B	-2.54%	78 Outperform

QEFA Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

95.27

Negative

100DMA

91.75

Positive

200DMA

88.17

Positive

Market Momentum

MACD

-0.23

Positive

RSI

39.77

Neutral

STOCH

25.16

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QEFA, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 97.65, equal to the 50-day MA of 95.27, and equal to the 200-day MA of 88.17, indicating a neutral trend. The MACD of -0.23 indicates Positive momentum. The RSI at 39.77 is Neutral, neither overbought nor oversold. The STOCH value of 25.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for QEFA.

QEFA Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
QEFA	―	―	$1.04B	0.30%	65 Neutral
JIRE	―	―	$9.94B	0.24%	68 Neutral
DBEF	―	―	$8.44B	0.35%	65 Neutral
FENI	―	―	$8.10B	0.28%	66 Neutral
BBIN	―	―	$6.01B	0.07%	67 Neutral
EFAV	―	―	$5.48B	0.20%	62 Neutral

Performance Comparison

QEFA

SPDR MSCI EAFE StrategicFactors ETF

94.46

17.60

22.90%

JIRE

JPMorgan International Research Enhanced Equity ETF

―

DBEF

Xtrackers MSCI EAFE Hedged Equity ETF

―

FENI

Fidelity Enhanced International ETF

―

BBIN

JPMorgan BetaBuilders International Equity ETF

―

EFAV

iShares MSCI EAFE Min Vol Factor ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents